By Nigam Arora & Dr. Natasha Arora
PLTR stock is long from $20.15. It is trading at $104.20 in the premarket. This represents a gain of 417%.
Earnings
Palantir reported earnings significantly better than the consensus and whisper numbers.
Technicals
The stock has rocketed past resistance. The power of the move is exemplified by the fact that the stock did not stop at the psychological resistance of $100.
Valuation
PLTR is the most expensive software stock. It is trading at a trailing PE of 440 and forward PE of 172.
Windfall Ahead
PLTR is likely to experience a windfall from Musk’s DOGE.
Challenge To Defense Industry
Palantir started out by doing work mostly for the Department of Defense. Now, Palantir is entering into several alliances to challenge the traditional defense industry.
Commercial Business
The earnings just reported show that Palantir is rapidly expanding its commercial business.
Zones
For those who are following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial) for the core position.
For those following the Best Way, the buy zone is $*** – $*** for the core position.
The recommended quantity is *** of the full core position size.
The very long term target is $156 – $163.
What To Do Now
Those in the stock may consider continuing to hold.
Those not in the stock may consider following the parameters given above.
Note: Signal(s) to enter, add, reduce, exit, hold or change.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.

Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.